What is he best known for?
The fields of study he is best known for:
His scientific interests lie mostly in Biochemistry, Pharmacology, Drug discovery, Transporter and Stereochemistry.
The study incorporates disciplines such as Biophysics and Cell biology in addition to Biochemistry.
His research in Pharmacology is mostly concerned with Pharmacokinetics.
His work in Pharmacokinetics covers topics such as In vivo which are related to areas like In vitro.
His work carried out in the field of Drug discovery brings together such families of science as ADME and Drug.
His study looks at the intersection of Bioinformatics and topics like Drug development with SLC47A1, Organic anion-transporting polypeptide, New drug application and Clinical trial.
His most cited work include:
- Membrane transporters in drug development. (2257 citations)
- ENDOCYTIC MECHANISMS FOR TARGETED DRUG DELIVERY (709 citations)
- Molecular basis of vitamin E action: tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-induced neurodegeneration. (246 citations)
What are the main themes of his work throughout his whole career to date?
Peter W. Swaan mostly deals with Biochemistry, Transporter, Pharmacology, Cell biology and Computational biology.
In his work, Dendrimer, Poly and Amidoamine is strongly intertwined with Biophysics, which is a subfield of Biochemistry.
His Transporter research is multidisciplinary, incorporating elements of Pharmacophore, Quantitative structure–activity relationship, Efflux and In silico.
The In silico study which covers Drug discovery that intersects with ADME.
His Pharmacology research includes elements of Virtual screening and Toxicity.
His biological study spans a wide range of topics, including Endocytic cycle, Receptor, Endocytosis and Drug delivery.
He most often published in these fields:
- Biochemistry (40.00%)
- Transporter (28.97%)
- Pharmacology (19.31%)
What were the highlights of his more recent work (between 2013-2021)?
- Transporter (28.97%)
- Pharmacology (19.31%)
- Biochemistry (40.00%)
In recent papers he was focusing on the following fields of study:
Peter W. Swaan mainly focuses on Transporter, Pharmacology, Biochemistry, Pharmacy and Bile acid.
His research integrates issues of Efflux and Glycosylation in his study of Transporter.
His study in Drug and DrugBank are all subfields of Pharmacology.
His Drug study which covers Toxicity that intersects with Carrier protein, Disease, Bioinformatics and Drug metabolism.
His research investigates the connection between Biochemistry and topics such as Monoamine transporter that intersect with problems in Membrane, Plasma membrane monoamine transporter and Organic cation transport.
His Multidrug Resistance-Associated Proteins research incorporates elements of Pharmacokinetics and Liver injury.
Between 2013 and 2021, his most popular works were:
- Risk factors for development of cholestatic drug-induced liver injury: inhibition of hepatic basolateral bile acid transporters multidrug resistance-associated proteins 3 and 4. (100 citations)
- Microfluidic Preparation of Liposomes to Determine Particle Size Influence on Cellular Uptake Mechanisms (75 citations)
- Potent and Selective Inhibition of Plasma Membrane Monoamine Transporter by HIV Protease Inhibitors. (33 citations)
In his most recent research, the most cited papers focused on:
Peter W. Swaan spends much of his time researching Transporter, Pharmacology, Cholestasis, Multidrug Resistance-Associated Proteins and Bile Salt Export Pump.
His Transporter study is related to the wider topic of Biochemistry.
His work on Organic cation transport proteins, Plasma membrane monoamine transporter and Organic cation transport as part of general Biochemistry research is often related to Lopinavir, thus linking different fields of science.
His study in the field of Drug and Drug metabolism also crosses realms of Extramural.
His study in Drug is interdisciplinary in nature, drawing from both Carrier protein, Disease, Toxicity and Bioinformatics.
Within one scientific family, Peter W. Swaan focuses on topics pertaining to Pharmacokinetics under Cholestasis, and may sometimes address concerns connected to Pharmaceutical sciences.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
